Drug profile

The FDA adverse-event record for Neomycin Sulfate, Isoflupredone Acetate And Tetracaine Hydrochloride

27 adverse-event reports submitted to the FDA Center for Veterinary Medicine reference Neomycin Sulfate, Isoflupredone Acetate And Tetracaine Hydrochloride. See the species affected, top reactions, and outcomes below.

27
adverse-event reports
11.1%
death-coded share
Dog
most-reported species
10
Emesis - top reaction
Verify with FDA CVM →
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
27
Total Reports
3
Deaths Reported
11.1%
Death Rate

Active Ingredients

Neomycin Sulfate, Isoflupredone Acetate And Tetracaine Hydrochloride

Administration Routes

TopicalUnknownCutaneousAuricular (Otic)Parenteral

Species Affected

Dog 25
Cattle 1
Cat 1

Most Affected Breeds

Retriever - Labrador 6
Retriever (unspecified) 2
Bulldog 2
Poodle (unspecified) 2
Terrier - Jack Russell 1
Rottweiler 1
Corgi - Welsh Cardigan 1
Bichon Frise 1
Retriever - Golden 1
Coton de Tuléar 1

Most Reported Reactions

Emesis 10
Lethargy (see also Central nervous system depression in 'Neurological') 6
Diarrhoea 4
Vomiting 3
Panting 3
Death 3
Behavioural disorder NOS 2
Elevated amylase 2
Vocalisation 2
Licking 2
Abdominal cavity disorder NOS 2
Anaemia NOS 2

Outcome Breakdown

Recovered/Normal
12 (44.4%)
Outcome Unknown
7 (25.9%)
Ongoing
4 (14.8%)
Died
3 (11.1%)
Recovered with Sequela
1 (3.7%)

Neomycin Sulfate, Isoflupredone Acetate And Tetracaine Hydrochloride Adverse Event Insights

27 reports name Neomycin Sulfate, Isoflupredone Acetate And Tetracaine Hydrochloride; 3 recorded a death outcome (11.1% of reported events, not a population-level mortality rate). Active ingredient: Neomycin Sulfate, Isoflupredone Acetate And Tetracaine Hydrochloride. Administration routes: Topical, Unknown, Cutaneous, Auricular (Otic).

By species: Dog (25 reports), Cattle (1 reports), Cat (1 reports). By breed: Retriever - Labrador (6), Retriever (unspecified) (2), Bulldog (2).

Leading clinical signs: Emesis (10), Lethargy (see also Central nervous system depression in 'Neurological') (6), Diarrhoea (4), Vomiting (3). Outcome, 27 coded reports: Recovered/Normal leads at 44.4%.

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. This page draws directly on FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.